Vulnerability Details : CVE-2019-11818
Alkacon OpenCMS v10.5.4 and before is affected by stored cross site scripting (XSS) in the module New User (/opencms/system/workplace/admin/accounts/user_new.jsp). This allows an attacker to insert arbitrary JavaScript as user input (First Name or Last Name), which will be executed whenever the affected snippet is loaded.
Vulnerability category: Cross site scripting (XSS)
Products affected by CVE-2019-11818
- cpe:2.3:a:alkacon:opencms:*:*:*:*:*:*:*:*
Threat overview for CVE-2019-11818
Top countries where our scanners detected CVE-2019-11818
Top open port discovered on systems with this issue
80
IPs affected by CVE-2019-11818 60
Threat actors abusing to this issue?
Yes
Find out if you* are
affected by CVE-2019-11818!
*Directly or indirectly through your vendors, service providers and 3rd parties.
Powered by
attack surface intelligence
from SecurityScorecard.
Exploit prediction scoring system (EPSS) score for CVE-2019-11818
0.14%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 49 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2019-11818
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
4.3
|
MEDIUM | AV:N/AC:M/Au:N/C:N/I:P/A:N |
8.6
|
2.9
|
NIST | |
6.1
|
MEDIUM | CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N |
2.8
|
2.7
|
NIST |
CWE ids for CVE-2019-11818
-
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.Assigned by: nvd@nist.gov (Primary)
References for CVE-2019-11818
-
https://www.openwall.com/lists/oss-security/2019/04/30/3
oss-security - Cross Site Scripting | Alkacon OpenCMS v10.5.4 and beforeMailing List;Exploit;Third Party Advisory
-
https://github.com/alkacon/opencms-core/issues/635
Cross Site Scripting | v10.5.4 | New User · Issue #635 · alkacon/opencms-core · GitHubExploit;Third Party Advisory
Jump to